Long-Term Evolocumab in Patients With Familial Hypercholesterolemia

Santos, RD; Stein, EA; Hovingh, GK; Blom, DJ; Soran, H; Watts, GF; Lopez, JAG; Bray, S; Kurtz, CE; Hamer, AW; Raal, FJ

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020; 75 (6): 565

Abstract

BACKGROUND Proprotein convertase subtilisin/kexin type 9 inhibitor therapy is a treatment option for patients with familial hypercholesterolemia (FH) ......

Full Text Link